Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
Setoyama T, Zhang X, Natsugoe S, Calin GA. Setoyama T, et al. Clin Cancer Res. 2011 Sep 1;17(17):5527-9. doi: 10.1158/1078-0432.CCR-11-1477. Epub 2011 Aug 4. Clin Cancer Res. 2011. PMID: 21816909 Free article.
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M. Nakata K, et al. Surgery. 2011 Nov;150(5):916-22. doi: 10.1016/j.surg.2011.06.017. Surgery. 2011. PMID: 22018284
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. Bloomston M, et al. JAMA. 2007 May 2;297(17):1901-8. doi: 10.1001/jama.297.17.1901. JAMA. 2007. PMID: 17473300
MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.
Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, Longnecker DS, Gutmann EJ, Sempere LF, Korc M. Preis M, et al. Clin Cancer Res. 2011 Sep 1;17(17):5812-21. doi: 10.1158/1078-0432.CCR-11-0695. Epub 2011 Jun 7. Clin Cancer Res. 2011. PMID: 21652542 Free PMC article.